Pharmacist Michael Witte, left, gives Rebecca Sirull, right, a shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus, Monday, March 16, 2020, at the Kaiser Permanente Washington Health Research Institute in Seattle. Sirull is the third patient to receive the shot in the study. (AP Photo/Ted S. Warren)
4 astronauts return to Earth after being delayed by Boeing's capsule trouble and Hurricane Milton Shares
Quarter Pounders are off the menu at 20% of McDonald's in US as E. coli cases are investigated Shares